hypoparathyroidism
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients who met the criteria for hypoparathyroidism and were prescribed conventional drug regimen between 180 and 300 days after meeting those criteria, from January 1, 2016 to June 30, 2024.
Exclusion criteria
Exclusion criteria: Not applicable
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| (1) Patient characteristics (patient demographics, laboratory test results, and comorbidities) (2) Treatment status (actual status of prescriptions under conventional therapy, and status of serum calcium level control under that therapy) (3) Clinical symptoms | — |
Countries
Japan
Contacts
Teijin Pharma Limited Medical Science Department